ACHILLION PHARMACEUTICAL (NASDAQ: ACHN)





$2.34 -0.08 (-3.31%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
3.89
52-Week Low Price
1.10
Avg Volume (3 Mo.)
1.00 M
Market Cap
0.06 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.94
Shares
26.66 M
Dividend Rate ($) / (%)
0.00/0.00
83%
17%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 87% - ACHN has outperformed the S&P 500 by 61%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
HEALTH DISCOVERY CORP (HDVY) $0.29 -  $0.02(6.45%)0.07 B
CARDIOVASCULAR SYSTEMS (CSII) $4.45 -  $0.09(2.06%)0.06 B
INHIBITEX INC (INHX) $1.04 -  $0.01(0.95%)0.06 B
NEURALSTEM INC (CUR) $1.90 -  $0.04(2.24%)0.06 B
SERACARE LIFE SCIENCES (SRLS) $3.66 -  $0.25(7.33%)0.06 B
THRESHOLD PHARMACEUTICAL (THLD) $1.75 -  $0.09(4.89%)0.06 B
AP PHARMA INC (APPA) $1.66 -  $0.00(0.00%)0.06 B
DYNAVAX TECHNOLOGIES CP (DVAX) $1.50 -  $0.06(4.17%)0.06 B
SKYSTAR BIO-PHARMA CO. (SKBI) $8.36 -  $0.14(1.70%)0.06 B
BIONOVO INC (BNVI) $0.51 -  $0.02(3.86%)0.06 B
STOCK ANALYSIS
There are currently no Stock Analysis.
ACHN RELATED HEADLINES
arrow
Achillion to Present at 12th Annual BIO CEO and Investor Conference
Achillion to Present at 12th Annual BIO CEO and Investor Conference

by GlobeNewswire 2/8/2010
arrow
Achillion Announces Closing of Underwriters' Over-Allotment Option
Achillion Announces Closing of Underwriters' Over-Allotment Option

by GlobeNewswire 2/2/2010
arrow
Achillion Announces License Agreement for Elvucitabine Development in China
Achillion Announces License Agreement for Elvucitabine Development in China

by GlobeNewswire 2/1/2010
arrow
Skymark Research Initiates Independent Research Coverage on Achillion Pharmaceuticals, Inc.
Skymark Research Initiates Independent Research Coverage on Achillion Pharmaceuticals, Inc.

by GlobeNewswire 1/29/2010
arrow
Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Program
Achillion Announces Nomination of ACH-2684 as Lead Clinical Candidate in Resistance-Focused HCV Program

by GlobeNewswire 1/28/2010
arrow
Achillion to Host Corporate and Clinical Update Conference Call on Monday, February 1, 2010
Achillion to Host Corporate and Clinical Update Conference Call on Monday, February 1, 2010

by GlobeNewswire 1/25/2010
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1